CSI Market
Sign In | Register

Remedent Inc (REMI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access REMI Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Remedent Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
9 Months 		(Sep 30 2020) (Jun 30 2020) (Mar 31 2020) (Dec 31 2019)
Operating Activities
Income0.11
Depreciation & amortization0.03
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.04
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.02
Increase (Decrease) in Inventories-0.02
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Payment To Acquire Equity Investment Rendered In Operating Activities-0.02
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.15
Increase (Decrease) in Accounts Payable, Trade0.08
Increase (Decrease) in Accrued Liabilities-0.08
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.11
Other Working Capital0.00
Other Noncash Income0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.07
Discontinued operations0.00
Net Cash flow from Operating Activities0.18
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Subsidiary Two-
Proceeds From Sale Of Subsidiary One-
Restricted Cash and Investments Increase (Decrease)0.00
Proceeds from Loan Originations0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Loan Originations-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow-0.21
Discontinued operations0.00
Free Cash Flow0.18
Total Cash Flow0.18
4 historic quarters locked

Sign in to unlock the full Remedent Inc cash flow history.

Sign In Create Free Account

About REMI Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.